Needham & Company LLC Reaffirms “Buy” Rating for DENTSPLY SIRONA (NASDAQ:XRAY)

Needham & Company LLC reaffirmed their buy rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY) in a research report released on Tuesday,Benzinga reports. The firm currently has a $25.00 target price on the medical instruments supplier’s stock.

A number of other equities research analysts have also recently commented on the stock. Evercore ISI reissued an “in-line” rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Barrington Research dropped their target price on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th. UBS Group decreased their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. Jefferies Financial Group lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating and dropped their price target for the stock from $30.00 to $20.00 in a research note on Thursday, January 23rd. Finally, Mizuho assumed coverage on shares of DENTSPLY SIRONA in a report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 price objective on the stock. Nine research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, DENTSPLY SIRONA has a consensus rating of “Hold” and an average target price of $26.33.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock opened at $18.28 on Tuesday. The company has a market capitalization of $3.63 billion, a PE ratio of -8.83, a P/E/G ratio of 1.83 and a beta of 0.96. The company has a 50-day simple moving average of $19.06 and a two-hundred day simple moving average of $22.07. DENTSPLY SIRONA has a one year low of $17.21 and a one year high of $34.91. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were given a dividend of $0.16 per share. The ex-dividend date was Friday, December 27th. This represents a $0.64 dividend on an annualized basis and a yield of 3.50%. DENTSPLY SIRONA’s dividend payout ratio is presently -30.92%.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. UMB Bank n.a. lifted its holdings in shares of DENTSPLY SIRONA by 430.3% in the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after buying an additional 753 shares during the period. Riverview Trust Co acquired a new position in DENTSPLY SIRONA in the fourth quarter valued at approximately $26,000. Capital Performance Advisors LLP acquired a new stake in shares of DENTSPLY SIRONA during the 3rd quarter worth approximately $27,000. MassMutual Private Wealth & Trust FSB grew its stake in shares of DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,232 shares during the period. Finally, Kennebec Savings Bank purchased a new position in shares of DENTSPLY SIRONA during the 3rd quarter valued at approximately $35,000. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.